• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 10 Aug 2025

Expect Sequential Improvement As SAS Delivers And FAM Stabilizes; Maintain 2025/26 Estimates As New Leadership Drives Early Execution Amid An Uneven Recovery; Maintain $16 Price Target


Schweitzer-Mauduit International (SWM:NYSE) | 0 0 0.0%


  • Sidoti & Company
    • Daniel Harriman

    • 10 pages


 

We maintain our prior 2025 estimates for MATV ahead of the company's 2Q:25 earnings release. While 1Q:25 results modestly exceeded expectations, we opt to remain conservative at this time. However, continued strength in the company's Sustainable & Adhesive Solutions (SAS) segment remains a strong point, in our view. Overall, we maintain our $505 million sales estimate for 2Q:25, which reflects 4.2% sequential growth. After recording its fifth consecutive quarter of margin growth in 1Q:25, we are looking for strength in SAS to drive EPS of $0.18 in 2Q:25 compared to a loss of $0.14 in the prior quarter. MATV's Filtration & Advanced Materials (FAM) segment has remained under pressure, particularly in paint protection films. However, given ongoing initiatives in the segment to stabilize performance, we model 4.2% sequential sales growth. We remain optimistic on MATV's long-term outlook and believe the company will benefit from CEO Shruti Singhal's clear turnaround strategy to improve commercial execution, reduce costs and streamline the product portfolio. Under Mr. Singhal, cost reduction and cash flow initiatives are underway. In 2025, the company aims to deliver $10 million-$15 million in cost reductions. With free cash flow (FCF) a top priority moving forward, the company says it expects to reduce capital spending to $40 million in 2025 (from $55 million in 2024).

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

Expect Sequential Improvement As SAS Delivers And FAM Stabilizes; Maintain 2025/26 Estimates As New Leadership Drives Early Execution Amid An Uneven Recovery; Maintain $16 Price Target


Schweitzer-Mauduit International (SWM:NYSE) | 0 0 0.0%


  • Published: 10 Aug 2025
  • Author: Daniel Harriman
  • Pages: 10
  • Sidoti & Company


We maintain our prior 2025 estimates for MATV ahead of the company's 2Q:25 earnings release. While 1Q:25 results modestly exceeded expectations, we opt to remain conservative at this time. However, continued strength in the company's Sustainable & Adhesive Solutions (SAS) segment remains a strong point, in our view. Overall, we maintain our $505 million sales estimate for 2Q:25, which reflects 4.2% sequential growth. After recording its fifth consecutive quarter of margin growth in 1Q:25, we are looking for strength in SAS to drive EPS of $0.18 in 2Q:25 compared to a loss of $0.14 in the prior quarter. MATV's Filtration & Advanced Materials (FAM) segment has remained under pressure, particularly in paint protection films. However, given ongoing initiatives in the segment to stabilize performance, we model 4.2% sequential sales growth. We remain optimistic on MATV's long-term outlook and believe the company will benefit from CEO Shruti Singhal's clear turnaround strategy to improve commercial execution, reduce costs and streamline the product portfolio. Under Mr. Singhal, cost reduction and cash flow initiatives are underway. In 2025, the company aims to deliver $10 million-$15 million in cost reductions. With free cash flow (FCF) a top priority moving forward, the company says it expects to reduce capital spending to $40 million in 2025 (from $55 million in 2024).

More Content

More Content

In Our View, 4Q:25 Seasonal Moderation Masks Structural Progress As Execution, Portfolio Discipline, And Deleveraging Continue; Maintain $21 Price Target

Companies: Schweitzer-Mauduit International

Sidoti & Company

Strong 2Q:25 Results Highlight Progress Of Turnaround; Cost Discipline, Commercial Execution, And FCF Momentum Support 2026 Estimate Revisions; Raise Price Target to $19 (From $16)

Companies: Schweitzer-Mauduit International

Sidoti & Company

2026 Preview: Cost Actions, Portfolio Focus, And Segment Stabilization Position MATV For Better Performance In First Full Year Under New Leadership; Maintain $21 Price Target

Companies: Schweitzer-Mauduit International

Sidoti & Company

MATV's Swift Recovery Gains Momentum Despite Market Uncertainty; Record Margins And Strong Cash Generation Underscore Good Execution, In Our View; Raise Price Target To $21 (From $19)

Companies: Schweitzer-Mauduit International

Sidoti & Company

Execution And Cost Discipline Support Steady 3Q:25 Results, In Our View, With FAM Recovery, SAS Momentum, Strong Cash Generation, And Deleveraging; Maintain $19 Price Target

Companies: Schweitzer-Mauduit International

Sidoti & Company
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2026

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Alternative Resource Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Morphose Capital Partners
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS Research Group
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Curious Compounder
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • ISTAR Capital
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • ISTAR Capital
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In